Where is Serox located?

Serox is headquartered in Oxford, United Kingdom.

Who is the current CEO of Serox?

Cici Muldoon of Serox. They have also founded 1 company.

Where does Serox rank among its competitors?

Serox ranks 41st amongst 118 active competitors, of which 20 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was PERSOWN, which secured an undisclosed amount in Jul, 2024.

Who are the top competitors of Serox?

Serox's top competitors include EKF, Cygnus Technologies and LumiraDx. Among them, PERSOWN secured the most recent funding round in July, 2024.

Serox - 2026 Company Profile, Team & Competitors

Company Details

Developer of point-of-care diagnostic platform using photonics and AI. The company designs low-cost, non-invasive clinical tools that analyze urine using advanced photonics and artificial intelligence to detect diseases at the point of need. Its technology uses spectral analysis of biological fluids to identify unique biochemical fingerprints, enabling rapid diagnosis of conditions such as cancers and urinary tract infections. The platform is intended to reduce reliance on invasive procedures by providing fast, accurate triage and screening in clinical or remote settings.

Key Metrics

Location

Oxford, United Kingdom

Stage

Unfunded

Ranked

41^st among 118 active competitors

Similar Companies

EKF & 118 more

View Serox's full profile

Serox has not raised any funding rounds yet.

The founders of Serox is Cici Muldoon. Cici Muldoon is the CEO of Serox.

Here are the details of Serox's key team members:

Cici Muldoon: Founder & CEO of Serox.

View details of Serox's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Serox include EKF, Cygnus Technologies and LumiraDx. Here is the list of Top 10 competitors of Serox, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	EKF 1990, Penarth (United Kingdom), Public	Develops point-of-care and laboratory blood analyzers	$179K	Octopus Investments, IBG Beteiligungsgesellschaft Sachsen-Anhalt ... & 2 others	54/100
2nd	Cygnus Technologies 2003, Southport (United States), Acquired	Manufacturer of analytical products for life science	-	-	51/100
3rd	LumiraDx 2014, Waltham (United States), Acquired	Cloud based diagnostics platform for point of care diagnosing	$704M	CYwP Funds, Petrichor & 10 others	49/100
4th	Achira 2009, Bengaluru (India), Series B	Provider of diagnostic medical devices for screening Covid 19	$13.1M	Cipla, Catamaran & 14 others	49/100
5th	LightDeck Diagnostics 2009, Boulder (United States), Acquired	Developer of point-of-care diagnostic device for multiplex assays	$57M	Entrada Ventures, Boulder Ventures & 8 others	48/100
6th	SpinChip 2012, Oslo (Norway), Acquired	R&D company focused on manufacturing in-vitro diagnostic test cartridge	$23.4M	Kistefos, Investinor	47/100
7th	Abaxis 1989, California City (United States), Acquired	Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests	-	NeoMed, MedVenture Associates & 1 others	44/100
8th	EDX Medical Group 2022, Cambridge (United Kingdom), Seed	Research laboratory focused on medical diagnostics solutions	$2.15M	Tsangs Group, Bridgemere & 2 others	44/100
9th	PERSOWN 2020, Jacksonville (United States), Seed	AI and cloud-based interoperable platforms for providers and patients	$2.96M	-	43/100
10th	ProciseDx 2018, San Diego (United States), Acquired	Provider of a point-of-care clinical diagnosis device for healthcare professionals	$22M	Nestlé Health Science, Biosynex & 1 others	42/100
41st	Serox Oxford (United Kingdom), Unfunded	Developer of point-of-care diagnostic platform using photonics and AI	-	-	24/100